Release Date: April 30, 2019 Expiration Date: April 30, 2020 (subject to change)
CE for this activity will not be available after this date.
Overview Many patients with plaque psoriasis experience negative health consequences that could be prevented or improved with optimal evidence-based care. Many clinicians remain unaware of the immune-mediated systemic nature of plaque psoriasis or how it shares immune pathophysiology with numerous comorbid conditions.
This this activity will examine the pathogenesis and diagnosis of plaque psoriasis and provide the opportunity for those who complete the program to pose questions for faculty in an “Ask the Expert” feature!
CE Credit Instructions
Read this activity description, including objectives and disclosures.
Complete the educational content completely:
Watch all presentations completely.
Review all additional materials provided (handouts, posttest reviews, all other downloadable resources).
After completing all content, go to Steps to Receive Credit:
Complete the activity posttest.
Complete the activity evaluation.
60 days after completion the learner will receive an invitation to an optional Post Impact Survey for this activity.
Objectives Upon completion of this presentation, the learner will be able to:
Describe plaque psoriasis as a systemic, immune-mediated disease.
Recognize the clinical presentation of plaque psoriasis and determine its severity based on body surface area, location, and impact on quality of life.
Identify co-morbid conditions often associated with plaque psoriasis.
Disclosure This activity was planned in accordance with AANP Accreditation Standards and Policies and has been created in collaboration with MCM Education. This activity is supported by independent educational grants from Novartis, AbbVie, and Celgene.
Lakshi Aldredge discloses that she has served on speakers’ bureaus and as a consultant for AbbVie, Celgene, Lilly, Novartis, Regeneron/Sanofi-Genzyme, and Sun Pharma. Peggy Vernon has no potential conflicts of interest to disclose.
This educational activity may contain opinions of the speakers from their personal experience. The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
Additional Information For questions about this online CE activity, or more information concerning the AANP CE Center, contact the AANP CE Center Manager at CECenter@aanp.org.
0.5 Contact Hour(s) of CE
Additional CE activities of interest
(OnDemand) Improving Outcomes in Plaque Psoriasis: The Role of the Nurse Practitioner, Activity B-Comorbidities and Management